![Michael Riley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Riley
Corporate Officer/Principal presso Intradigm Corp.
Profilo
Michael Riley currently works at Intradigm Corp., as VP-Intellectual Property & Corporate Development from 2006.
Mr. Riley also formerly worked at Amgen, Inc., as Principal, Abgenix, Inc., as Principal, Celltech Group Plc, as Principal, and Silence Therapeutics Plc, as SVP-Corporate Development & Intellectual Property.
Mr. Riley received his graduate degree from the University of North Dakota.
Posizioni attive di Michael Riley
Società | Posizione | Inizio |
---|---|---|
Intradigm Corp.
![]() Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01/08/2006 |
Precedenti posizioni note di Michael Riley
Società | Posizione | Fine |
---|---|---|
SILENCE THERAPEUTICS PLC | Corporate Officer/Principal | - |
Abgenix, Inc.
![]() Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | - |
AMGEN INC. | Corporate Officer/Principal | - |
Formazione di Michael Riley
University of North Dakota | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
AMGEN INC. | Health Technology |
SILENCE THERAPEUTICS PLC | Commercial Services |
Aziende private | 3 |
---|---|
Intradigm Corp.
![]() Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Abgenix, Inc.
![]() Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Michael Riley